Neurovascular Interventional Devices for Hemorrhagic Stroke – Global Market Analysis and Outlook 2020-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Neurovascular Interventional Devices for Hemorrhagic Stroke Market” report has been added to ResearchAndMarkets.com’s offering.
This report covers the impact of COVID-19 on the neurovascular interventional devices for hemorrhagic stroke market, including a recent forecast from 2020 to 2025.
COVID-19 has impacted leading competitors, such as Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and others. The report provides insights into trends, drivers, and limiters of the neurovascular devices for hemorrhagic stroke market, as well as highlights potential opportunities.
Information covered by this report includes:
- Unit volumes & pricing forecast from 2020-2025,
- Analyses of the leading companies, and
- Global market share analysis.
Companies Mentioned
- Abbott
- Boston Scientific
- Cerenovus/J&J
- Cordis Cardinal Health
- Evasc
- Microport
- Microvention/Terumo
- Micrus
- Penumbra
- Target/Stryker
For more information about this report visit https://www.researchandmarkets.com/r/vu0ftm
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
